HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mohammad Hossein Nasr-Esfahani Selected Research

Peroxisomal Targeting Signal 2 Receptor

4/2013Identification of a novel missense mutation of PEX7 gene in an Iranian patient with rhizomelic chondrodysplasia punctata type 1.
1/2013C86Y: as a destructive homozygous mutation deteriorating Pex7p function causing rhizomelic chondrodysplasia punctata type I.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mohammad Hossein Nasr-Esfahani Research Topics

Disease

14Varicocele
05/2022 - 08/2014
8Male Infertility (Male Sterility)
05/2022 - 01/2013
7Neoplasms (Cancer)
09/2021 - 01/2013
6Infertility (Sterility)
05/2022 - 02/2010
6Neurodegenerative Diseases (Neurodegenerative Disease)
04/2019 - 03/2014
5Inflammation (Inflammations)
04/2022 - 01/2016
4Obesity
09/2022 - 11/2018
4Insulin Resistance
09/2022 - 07/2021
3Multiple Sclerosis
08/2021 - 10/2017
3Nervous System Diseases (Neurological Disorders)
05/2021 - 12/2013
3Autoimmune Diseases (Autoimmune Disease)
09/2018 - 01/2015
3Cardiotoxicity
01/2018 - 10/2009
3Spinal Cord Injuries (Spinal Cord Injury)
03/2015 - 01/2012
2Azoospermia
07/2022 - 03/2020
2Retinal Degeneration
06/2022 - 01/2012
2Prediabetic State (Prediabetes)
01/2022 - 07/2021
2Oligospermia (Oligozoospermia)
11/2021 - 04/2020
2Demyelinating Diseases (Demyelinating Disease)
08/2021 - 10/2017
2Teratozoospermia
04/2021 - 01/2016
2Heart Failure
03/2021 - 11/2014
2Carcinoma (Carcinomatosis)
01/2020 - 09/2016
2Rhizomelic Chondrodysplasia Punctata
04/2013 - 01/2013
1Colonic Neoplasms (Colon Cancer)
09/2022
1Cytokine Release Syndrome
05/2022
1Infections
05/2022
1Blindness (Hysterical Blindness)
03/2022
1Weight Gain
01/2022
1Genomic Instability
11/2021
1COVID-19
09/2021
1Adenocarcinoma
09/2021
1Colitis
08/2021
1Megalencephaly
08/2021
1Glucose Intolerance
07/2021
1Body Weight (Weight, Body)
07/2021
1Mitochondrial Diseases (Mitochondrial Disease)
05/2021
1Fatty Liver
04/2021
1Non-alcoholic Fatty Liver Disease
04/2021
1Cognitive Dysfunction
03/2021

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
11/2021 - 02/2010
8MicroRNAs (MicroRNA)IBA
05/2021 - 01/2015
6Messenger RNA (mRNA)IBA
04/2022 - 02/2010
6AntioxidantsIBA
04/2022 - 01/2019
6DNA (Deoxyribonucleic Acid)IBA
11/2021 - 08/2014
5Protamines (Protamine Sulfate)FDA Link
11/2021 - 08/2014
5Reactive Oxygen Species (Oxygen Radicals)IBA
10/2020 - 04/2016
4salicylhydroxamic acid (SHAM)IBA
02/2022 - 08/2014
4ChromatinIBA
08/2021 - 01/2019
3EnzymesIBA
04/2022 - 01/2021
3Biomarkers (Surrogate Marker)IBA
11/2021 - 09/2018
3Peptides (Polypeptides)IBA
09/2021 - 01/2018
3Pharmaceutical PreparationsIBA
03/2021 - 10/2017
3RNA (Ribonucleic Acid)IBA
01/2021 - 01/2016
3Histones (Histone)IBA
12/2020 - 01/2019
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018 - 10/2009
2Glutathione (Reduced Glutathione)IBA
04/2022 - 01/2020
2Retinaldehyde (Retinal)IBA
03/2022 - 01/2012
2Blood Glucose (Blood Sugar)IBA
01/2022 - 07/2021
2Insulin (Novolin)FDA Link
01/2022 - 07/2021
2Long Noncoding RNAIBA
07/2021 - 01/2020
2Brain-Derived Neurotrophic Factor (BDNF)IBA
05/2021 - 03/2016
2Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2021 - 09/2016
2MyokinesIBA
01/2020 - 11/2014
2CaspasesIBA
03/2019 - 04/2013
2Pioglitazone (Actos)FDA Link
03/2018 - 03/2014
2Peroxisomal Targeting Signal 2 ReceptorIBA
04/2013 - 01/2013
2Dexamethasone (Maxidex)FDA LinkGeneric
04/2013 - 10/2009
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
09/2022
1Nonesterified Fatty Acids (NEFA)IBA
09/2022
1Neuroprotective AgentsIBA
06/2022
1InflammasomesIBA
05/2022
1CystathionineIBA
04/2022
1LyasesIBA
04/2022
1Vitamin DFDA LinkGeneric
04/2022
1CurcuminIBA
02/2022
1CoffeeFDA Link
01/2022
1Chlorogenic AcidIBA
01/2022
1Indicators and Reagents (Reagents)IBA
11/2021
1Glucose (Dextrose)FDA LinkGeneric
11/2021
1ChitosanIBA
09/2021
1Melitten (Melittin)IBA
09/2021
1PolyelectrolytesIBA
09/2021
1Viral RNAIBA
09/2021
1Gonadal Steroid Hormones (Sex Hormones)IBA
09/2021
1Interleukin-6 (Interleukin 6)IBA
08/2021
1Sirtuin 1IBA
08/2021
1Peroxidase (Myeloperoxidase)IBA
08/2021
1CuprizoneIBA
08/2021
1Therapeutic UsesIBA
08/2021
1Bee Venoms (Bee Venom)IBA
08/2021
1ApaminIBA
08/2021
1Advanced Glycation End ProductsIBA
07/2021
1diacetyldichlorofluoresceinIBA
07/2021
14,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA
07/2021
1sacubitril and valsartan sodium hydrate drug combinationIBA
03/2021
1Angiotensin Receptors (Angiotensin II Receptor)IBA
03/2021

Therapy/Procedure

6Therapeutics
01/2021 - 12/2013
3Transplantation
07/2012 - 01/2012
2Endurance Training
04/2021 - 11/2018
2Drug Therapy (Chemotherapy)
01/2021 - 01/2018
1Contraception (Birth Control)
07/2022